Humana Inc. HUM
Set alert
414.25 USD +3.84 +0.94%
As of Nov 3, 10:49 AM ET
407.36 Day range 416.90
163.67 52-week range 433.50
- YTD
- +61.73%
- 1 year
- +47.99%
- Open
- 407.87
- Prev close
- 410.41
- Mkt cap
- 49.73B
- Vol
- 141.87K
- Avg vol
- 1.24M
- EPS
- 10.58
- P/E
- 39.15
- Div yield
- 0.85%
More statistics
- Low
- 407.36
- High
- 416.90
- Forward P/E
- 24.01
- Beta
- 0.64
- Short ratio
- 2.41
- Inst. own
- 101.38%
- Dividend
- 3.54
- Ex-div date
- Dec 23, 2026
- Earnings
- Nov 6, 2026
- 50-d avg
- 401.03
- 200-d avg
- 308.34
- 1y target
- 465.13
YTD chart
Events in this range
- Feb 11, 2026Earnings: -3.96; estimate -4; surprise 1%
- Mar 27, 2026Dividend: 0.885
- Apr 29, 2026Earnings: 10.31; estimate 10.24; surprise 0.68%
- Jun 26, 2026Dividend: 0.885
- Jul 29, 2026Earnings: 7.61; estimate 7.27; surprise 4.68%
- Oct 9, 2026Rating: Barclays · Overweight → Overweight
- Oct 12, 2026Rating: Raymond James · Market Perform → Outperform
- Oct 12, 2026Rating: Oppenheimer · Outperform → Outperform
- Oct 12, 2026Rating: Truist Securities · Hold → Hold
- Oct 12, 2026Rating: UBS · Neutral → Neutral
- Oct 13, 2026Rating: Mizuho · Outperform → Outperform
- Oct 30, 2026Dividend: 0.885
Signals (43)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 26, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 5, 2026 | 4 weeks ago |
| SMA: Bullish | Oct 2, 2026 | 1 month ago |
| SMA: Bearish | Sep 30, 2026 | 1 month ago |
| SMA: Bullish | Sep 25, 2026 | 1 month ago |
| SMA: Bearish | Sep 16, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 16, 2026 | 1 month ago |
| SMA: Bullish | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 24, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 20, 2026 | 2 months ago |
| SMA: Bearish | Aug 18, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 13, 2026 | 2 months ago |
| SMA: Bullish | Aug 12, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 7, 2026 | 2 months ago |
| SMA: Bearish | Aug 4, 2026 | 3 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
Newest 20 of 43.
Analyst view
Consensus: buy
Buy
Price target (mean) 465.13 +12.3% upside
Now 414.25
- Target (low)
- 280.00
- Target (mean)
- 465.13
- Target (high)
- 596.00
Ratings (0m) 26 16 buy · 9 hold · 1 sell
- Strong buy3
- Buy13
- Hold9
- Sell1
- Strong sell0
Recommendation trend
- This month 26
- 1 month ago 26
- 2 months ago 26
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.00 | -1.16 – -0.60 | 3.24 | -131.0% | 40.89B | +25.2% | 23 |
| Next quarter | -7.86 | -10.65 – -6.61 | -3.96 | -98.6% | 41.26B | +26.9% | 23 |
| Current year | 9.16 | 8.45 – 10.55 | 17.14 | -46.6% | 162.80B | +25.6% | 26 |
| Next year | 17.09 | 10.39 – 20.75 | 9.16 | +86.6% | 168.69B | +3.6% | 26 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 13, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Oct 12, 2026 | UBS | Maintained | Neutral | Neutral |
| Oct 12, 2026 | Truist Securities | Maintained | Hold | Hold |
| Oct 12, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Oct 12, 2026 | Raymond James | Upgrade | Market Perform | Outperform |
| Oct 9, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 9, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Oct 9, 2026 | Baird | Upgrade | Neutral | Outperform |
| Oct 7, 2026 | Cantor Fitzgerald | Upgrade | Neutral | Overweight |
| Sep 25, 2026 | Barclays | Upgrade | Equal-Weight | Overweight |
| Aug 10, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Aug 5, 2026 | Morgan Stanley | Upgrade | Underweight | Equal-Weight |
| Jul 31, 2026 | TD Cowen | Maintained | Hold | Hold |
| Jul 31, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jul 30, 2026 | UBS | Maintained | Neutral | Neutral |
| Jul 30, 2026 | Evercore ISI Group | Upgrade | In-Line | Outperform |
| Jul 30, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 30, 2026 | Raymond James | Downgrade | Outperform | Market Perform |
| Jul 14, 2026 | TD Cowen | Maintained | Hold | Hold |
| Jul 14, 2026 | Truist Securities | Maintained | Hold | Hold |
| Jul 13, 2026 | Wells Fargo | Upgrade | Equal-Weight | Overweight |
| Jul 9, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Jul 7, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Jun 24, 2026 | B of A Securities | Maintained | Neutral | Neutral |
| Jun 11, 2026 | Evercore ISI Group | Maintained | In-Line | In-Line |
| Jun 8, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jun 8, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Jun 4, 2026 | B of A Securities | Maintained | Neutral | Neutral |
| Jun 4, 2026 | Morgan Stanley | Maintained | Underweight | Underweight |
| Jun 1, 2026 | Truist Securities | Maintained | Hold | Hold |